Home › Funds › Granite Investment Partners, LLC › LGND

Granite Investment Partners, LLC position in LGND

LIGAND PHARMACEUTICALS INC · Health Care

Granite Investment Partners, LLC reported holding 54,128 shares of LGND (LIGAND PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$17.1M, representing 0.88% of its reported portfolio and ranking #24 among its reported holdings. Granite Investment Partners, LLC has disclosed LGND holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)54.13K sh
Reported value held$17.11M
Portfolio Weight0.88%
First reportedQ3 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Granite Investment Partners, LLC's LGND position evolved

Granite Investment Partners, LLC first disclosed a stake in LGND in Q3 2024 at 118,001 shares (US$11.8M). The position peaked in Q2 2026 at 54,128 shares, worth US$17.1M. Across 8 filings, Granite Investment Partners, LLC increased the stake 1 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 54,128 shares valued at US$17.1M. Notable position changes include a 50% trim in Q3 2025 (shares rose 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 118.00K $11.81M New
Q4 2024 115.54K $12.38M Reduce
Q1 2025 133.13K $14.00M Add
Q2 2025 124.46K $14.15M Reduce
Q3 2025 61.62K $10.92M Reduce
Q4 2025 57.93K $10.95M Reduce
Q1 2026 54.16K $10.81M Reduce
Q2 2026 54.13K $17.11M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LGND and 13F data

LGND (LIGAND PHARMACEUTICALS INC) is a Health Care company. 58 other funds we track also report a position in LGND — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$205.7M), Chicago Capital, LLC (US$172.2M), Stephens Investment Management Group LLC (US$150.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LGND

All LGND fund holders →

FAQ

How long has Granite Investment Partners, LLC held LGND?

Granite Investment Partners, LLC has disclosed LGND holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is Granite Investment Partners, LLC's current position in LGND?

As of Q2 2026, Granite Investment Partners, LLC holds 54.13K shares of LGND (LIGAND PHARMACEUTICALS INC), valued at $17.11M, representing 0.88% of its reported portfolio and ranking #24.

Has Granite Investment Partners, LLC been buying or selling LGND?

In the latest 13F filing (Q2 2026), Granite Investment Partners, LLC held unchanged its position in LGND. The position peaked in Q2 2026 at 54.13K shares.

Which other funds hold LGND?

Other major institutional holders of LGND include CONGRESS ASSET MANAGEMENT CO, Chicago Capital, LLC, Stephens Investment Management Group LLC, among 58 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.